SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    RosenfeldRG, RobertsCTJr, eds. The IGF system. Totowa, NJ: Humana Press, 1999.
  • 2
    LeRoithD, ZumkellerW, BaxterR. eds. Insulin-like growth factors. Georgetown, TX: Landes Bioscience, 2002.
  • 3
    Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-1 receptors. Endocrine Rev 2001; 22: 81835.
  • 4
    Mauro L, Salerno ME, Morelli C, Roterberg T, Bracke ME, Surmacz E. Role of the IGF-1 receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol 2002; 194: 10816.
  • 5
    Baserga R, Prisco M, Yuan T. IGF-1 receptor signaling in health and disease. In: LeRoithD, ZumkellerW, BaxterR, eds. Insulin-like growth factors. Georgetown, TX: Landes Bioscience, 2002: 120140.
  • 6
    Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA 1993; 90: 1121721.
  • 7
    Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 1994; 14: 360412.
  • 8
    Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75: 5972.
  • 9
    Reiss K, Valentinis B, Tu X, Xu SQ, Baserga R. Molecular markers of IGF-1-mediated mitogenesis. Exp Cell Res 1998; 242: 36172.
  • 10
    Xu SQ, Tang D, Chamberlain S, Pronks G, Masiarz FR, Kaur S, Prisco M, Zanocco-Marani T, Baserga R. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem 1998; 273: 2007883.
  • 11
    He Z, Bateman A. Progranulin gene expression tegulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 1999; 59: 32229.
  • 12
    Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PHB. ETV6-NTRK3 transformation requires insulin-like growth factor I receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation. Oncogene 2002; 21: 568495.
  • 13
    Valentinis B, Morrione A, Taylor SJ, Baserga R. Insulin-like growth factor 1 receptor signaling in transformation by src oncogenes. Mol Cell Biol 1997; 17: 374454.
  • 14
    Liu JL, Blakesley VA, Gutkind JS, LeRoith D. The constitutively active mutant Gα13 transforms mouse fibroblast cells deficient in insulin-like growth factor-I receptor. J Biol Chem 1997; 272: 2943841.
  • 15
    White MF. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 1998; 182: 311.
  • 16
    Zhou-Li F, Xu S-Q, Dews M, Baserga R. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene 1997; 15: 96170.
  • 17
    Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000; 19: 557481.
  • 18
    Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. Growth inhibition of human melanoma cells in nude mice by antisensense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 1994; 54: 484850.
  • 19
    Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor I (IGF-1) receptor are non-tumorigenic and induce regression of wild-type tumors. Cancer Res 1994; 54: 221822.
  • 20
    Reiss K, D'Ambrosio C, Tu X, Tu C, Baserga R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with the by-stander effect. Clin Cancer Res 1998; 4: 264755.
  • 21
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D. A chimeric humanized single-chain antibody against the type 1 insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effect of IGF-1. Cancer Res 2003; 63: 62735.
  • 22
    Long L, Rubin R, Baserga R, Brodt P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor I receptor. Cancer Res 1995; 55: 10069.
  • 23
    Dunn SE, Ehrlich M, Sharp NJH, Reiss K, Solomon G, Hawkins R, Baserga R, Barrett JC. A dominant negative mutant of the insulin-like growth factor 1 receptor inhibits the adhesion, invasion and metastasis of breast cancer. Cancer Res 1998; 58: 335361.
  • 24
    Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky MI, Shiloh Y. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene 2001; 20: 402940.
  • 25
    Liu X, Turbyville T, Fritz A, Whitesell L. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res 1998; 58: 54328.
  • 26
    Adachi Y, Lee CT, Coffee K, Yamagata N, Ohm JE, Park KH, Dikov MM, Nadaf SR, Arteaga CL, Carbone DP. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology 2002; 123: 1191204.
  • 27
    Shapiro DN, Jones BG, Shapiro LH, Dias P, Houghton PJ. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest 1994; 94: 123542.
  • 28
    Kalebic T, Tsokos M, Helman LJ. In vivo treatment with antibody against the IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down regulates p34/cdc2. Cancer Res 1994; 54: 55314.
  • 29
    Lee CT, Wu S, Gabrivolich D, Chen H, Nadaf-Rahrov S, Ciernick IF, Carbone DP. Antitumor effect of an Adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res 1996; 56: 303841.
  • 30
    Scotlandi K, Avnet S, Benini S, Manara MC, Serra M, Cerisano V, Perdichizzi S, Lollini PL, DeGiovanni C, Landuzzi L, Picci P. Expression of an IGF-1 receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. Int J Cancer 2002; 101: 116.
  • 31
    Wang JY, Del Valle L, Gordon J, Rubini M, Romano G, Croul S, Peruzzi F, Khalili K, Reiss K. Activation of the IGF-1R system contributes to malignant growth of human and mouse medulloblastoma. Oncogene 2001; 20: 385768.
  • 32
    Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Rev 2000; 21: 21544.
  • 33
    Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan I. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci 1996; 93: 72638.
  • 34
    Conlon MA, Tomas FM, Owens PC, Wallace JC, Howarth GS, Ballard FJ. Long R/3 insulin-like growth factor I (IGF-1) infusion stimulates organ growth but reduces plasma IGF-1, IGF-1I and IGF binding protein concentrations in the guinea pig. J Endocrin 1995; 146: 24753.
  • 35
    Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor 1 receptor in a pathway regulating radiation response. Proc Natl Acad Sci 2001; 98: 167681.
  • 36
    Hartwell LH. Cell division from a genetic perspective. J Cell Biol 1978; 77: 62737.
  • 37
    Jorgensen P, Nishikawa JL, Breitkreutz BJ, Tyers M. Systematic identification of pathways that couple cell growth and division in yeast. Science 2002; 297: 395400.
  • 38
    Moss T, Stefanovsky VY. Promotion and regulation of ribosomal transcription in eukaryotes by RNA polymerase I. Progr Nucl Acid Res Mol Biol 1995; 50: 2566.
  • 39
    Grummt I. Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Progr Nucl Acid Res Mol Biol 1999; 62: 10953.
  • 40
    Voit R, Kuhn A, Sander EE, Grummt I. Activation of mammalian ribosomal gene transcription requires phosphorylation of the nucleolar transcription factor UBF. Nucl Acids Res 1995; 23: 25939.
  • 41
    Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998; 42: 95576.
  • 42
    Pete G, Fuller GR, Oldham JM, Smith DR, D'Ercole AJ, Kahn CR, Lund PK. Postnatal growth responses to insulin-like growth factor 1 in insulin receptor substrate-1 mice. Endocrinology 1999; 140: 547887.
  • 43
    Bohni R, Riesco-Escovar J, Oldham S, Brogiolo W, Stocker H, Andruss BF, Beckingham K, Hafen E. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS-1. Cell 1999; 97: 86575.
  • 44
    Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. Disruption of the p70S6K/p85S6K gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998; 17: 664959.
  • 45
    Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. Drosophila 6 kinase: a regulator of cell size. Science 1999; 285: 21269.
  • 46
    Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat Cell Biol 1999; 1: 5006.
  • 47
    Vandromme M, Rocha A, Meier R, Carnac G, Besser D, Hemmings BA, Fernandez A, Lamb NJC. Protein kinase Bβ/Akt2 plays a specific role in muscle differentiation. J Biol Chem 2001; 276: 81739.
  • 48
    Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, José PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Gen 1996; 12: 1069.
  • 49
    Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R. Insulin receptor substrate-1, p70S6K and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 2000; 275: 254519.
  • 50
    Lassak A, DelValle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K, Reiss K. Insulin receptor substrate-1 translocation to the nucleus by the human JC virus T antigen. J Biol Chem 2002; 277: 172318.
  • 51
    Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R. Nuclear translocation of IRS-1 by the SV40 T antigen and the activated IGF-1 receptor. J Biol Chem 2002; 277: 3207885.
  • 52
    Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R. Nuclear translocation of insulin receptor substrate-1 by oncogenes and IGF-1: effect on ribosomal RNA synthesis. J Biol Chem 2002; 277: 4435765.
  • 53
    Boylan JM, Gruppuso PA. Insulin receptor substrate-1 is present in hepatocyte nuclei from intact rats. Endocrinology 2002; 143: 417883.
  • 54
    Sun HZ, Tu X, Prisco M, Wu A, Casiburi I, Baserga R. IGF-1 receptor signaling and nuclear translocation of insulin receptor substrates-1 and –2. Mol Endocrinol 2003; 17: 47286.
  • 55
    Wu A, Sciacca L, Baserga R. Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts. J Cell Physiol 2003; 195: 45360.
  • 56
    Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A, Baserga R. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 1999; 274: 1242330.
  • 57
    Baserga R. Growth in size and cell DNA replication. Exp Cell Res 1984; 151: 15.
  • 58
    Lerch-Gagg A, Haque J, Li J, Ning G, Traktman P, Duncan SA. Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation. J Biol Chem 2002; 277: 4534755.
  • 59
    O'Brien T, Tjian R. Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes. Proc Natl Acad Sci 2000; 97: 245661.
  • 60
    Lin CY, Tuan JA, Scalia P, Bul T, Comai L. The cell cycle regulatory factor TAF1 stimulates ribosomal DNA transcription by binding to the activator UBF. Curr Biol 2002; 12: 21426.
  • 61
    Iben S, Tschochner H, Bler M, Hoogstraten D, Hozak P, Egly JM, Grummt I. TFIIH plays an essential role in RNA polymerase I transcription. Cell 2002; 109: 297306.
  • 62
    Voit R, Hoffmann M, Grummt I. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J 1999; 18: 18919.
  • 63
    Andersen JS, Lyon CE, Fox AH, Leung AKL, Lam YW, Steen H, Mann M, Lamond AI. Directed proteomic analysis of the human nucleolus. Curr Biol 2002; 12: 111.
  • 64
    Scherl A, Couté Y, Deon C, Callé A, Kinbeiter K, Sanches JC, Greco A, Hochstrasser D, Diaz JJ. Functional proteomic analysis of human nucleolus. Mol Biol Cell 2002; 13: 41009.
  • 65
    Kiely PA, Sant A, O'Connor R. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem 2002; 277: 225819.